COPD patients with COVID-19 are usually characterized by the higher level of ACE2 expression in the respiratory tract (Leung et al., 2020; Milne et al., 2020), which in turn might have increased the susceptibility of the host to SARS-CoV-2 infection. This evidence concerns the gene ACE2 and COVID-19.